Streetbeat News

Products Services

AMRN

The Portuguese Ministry of Health has approved VAZKEPA for national reimbursement to reduce cardiovascular risk in high-risk patients. This marks the eighth national reimbursement in Europe. Amarin will begin commercialization in Portugal on August 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 8:18 pm

XOM

Deep-pocketed investors are showing a bullish approach towards Exxon Mobil (NYSE:XOM), with significant options activity observed. The majority of the options are calls, indicating a positive sentiment. Analysts have mixed ratings but generally high price targets for XOM.

Portfolio Pulse from Benzinga Insights

July 17, 2024 | 8:16 pm

SLG

SL Green Realty has announced the sellout of Giorgio Armani Residences on Manhattan's Upper East Side, with all 10 units under contract for a total of $168.2 million. The sales are expected to close in Q4 2024.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 8:13 pm

ASTH

Astrana Health has announced a strategic partnership with Elation Health to launch a value-based care solution in Hawai'i. This partnership aims to provide high-quality, accessible healthcare through Elation's EHR platform, which is used by over 32,000 clinicians caring for 15 million patients.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 8:10 pm

RARE

Ultragenyx has reached an agreement with the FDA on the endpoints for its Phase 3 study of GTX-102. The Phase 3 study is set to begin by the end of the year, following a successful end-of-Phase 2 meeting. The study will be a global double-blind sham-controlled pivotal study, with an additional study planned for patients with other mutations.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 8:06 pm

PFE

VALN

Pfizer Inc. and Valneva SE announced the completion of the primary vaccination series in their Phase 3 VALOR Lyme Disease trial. Participants received three doses of the VLA15 vaccine and will be monitored until the end of the Lyme disease season in 2025.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 8:02 pm

F

Ford Pro has introduced the Ford Pro Smart Charging Bundle in California, aiming to enhance electric vehicle charging solutions in the state.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 8:01 pm

META

VGK

Meta will not offer its future multimodal AI models in the EU due to regulatory uncertainties. This decision highlights growing tensions between U.S. tech giants and European regulators. Meta's move could impact European companies and consumers, as well as the competitiveness of European firms.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 7:59 pm

FDMT

4D Molecular Therapeutics (FDMT) shares are trading lower following the announcement of interim data from their Phase 2 PRISM study.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 7:52 pm

NVDA

CoreWeave CEO Mike Intrator highlighted the relentless demand for Nvidia's AI chips, noting that customers are exclusively seeking Nvidia technology. Despite offering various options, CoreWeave's clients are only interested in Nvidia chips due to their performance. Nvidia has consistently exceeded financial expectations and is seen as a key player in the AI revolution. Nvidia shares have surged 138% year-to-date, although they were down 6.59% at the time of publication.

Portfolio Pulse from Adam Eckert

July 17, 2024 | 7:48 pm